FIGURE 5
FROM:
Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases
Yvonne Bury, Dagmar Ruf, Christina Mørk Hansen, Anne-Marie Kissmeyer, Lise Binderup and Carsten Carlberg
BACK TO ARTICLEFigure 5.

Agonistic effects of 1
,25(OH)2D3 and its analogs in vivo. Luciferase reporter gene assays were performed with extracts from HeLa cells that were transiently transfected with a reporter gene construct-driven by three copies of the GAL4 binding site and an expression vector for a GAL4DBDVDRLBD fusion protein (as schematically depicted above). The cells were treated for 16 h with graded concentrations of 1
,25(OH)2D3 or its analogs. Stimulation of luciferase activity was calculated in comparison with solvent-induced controls. Data points represent the mean of triplicates and the bars indicate SD. The EC50 values for stimulation of VDR-driven gene activity were determined from the respective dose–response curves.
